Romanelli Joseph — SEC Form 4 filings
SEC reporting owner CIK 1938322. 9 Form 4 filings on record with FilingPulse; latest filed 2026-01-28.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-14 to 2026-01-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 1,000 shares, $124,888 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 1,000 shares @ $124.89 ($124,888) in Merck & Co., Inc., filed 2024-02-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Merck & Co., Inc. (MRK) | President, Human Health Int?l | 6 | — | 1 leg · 1,000 sh · $124,888 | 15 |
| KIMBERLY CLARK CORP (KMB) | Director | 3 | — | — | 3 |
Form 4 filings — Romanelli Joseph
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-28 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 5,703 @ $107.40 | EDGAR |
| 2026-01-05 | 4 | KIMBERLY CLARK CORP (KMB) | Grant/award (A): 1,923 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4/A | Merck & Co., Inc. (MRK) | Holdings only — no transactions reported | EDGAR |
| 2025-05-02 | 4 | Merck & Co., Inc. (MRK) | Option exercise (M): 2,063 @ $84.71 · Tax withholding (F): 1,017 @ $84.71 · Option exercise (M): 2,262 @ $83.26 · Tax withholding (F): 1,115 @ $83.26 · Option exercise (M): 2,063 (derivative) @ $0 · Option exercise (M): 2,262 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 4,722 (derivative) @ $0 · Grant/award (A): 9,444 (derivative) @ $0 · Grant/award (A): 21,494 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | KIMBERLY CLARK CORP (KMB) | Grant/award (A): 1,493 (derivative) @ $0 | EDGAR |
| 2024-11-14 | 4 | KIMBERLY CLARK CORP (KMB) | Grant/award (A): 233 (derivative) @ $0 | EDGAR |
| 2024-05-02 | 4 | Merck & Co., Inc. (MRK) | Option exercise (M): 2,262 @ $128.80 · Tax withholding (F): 1,115 @ $128.80 · Grant/award (A): 6,191 (derivative) @ $0 · Grant/award (A): 23,438 (derivative) @ $0 · Option exercise (M): 2,262 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | Merck & Co., Inc. (MRK) | Sale (S): 1,000 @ $124.89 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1938322 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →